Current Report Filing (8-k)
17 November 2016 - 8:18AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November
10, 2016
EVINE Live Inc.
(Exact name of registrant as specified in
its charter)
Minnesota
|
001-37495
|
41-1673770
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
6740 Shady Oak Road
Eden Prairie, Minnesota 55344-3433
(Address of principal executive offices)
(952) 943-6000
(Registrant’s telephone number, including
area code)
Not applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
|
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 3.02.
|
Unregistered Sales of Equity
Securities.
|
On September 14, 2016, EVINE Live Inc.
(the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain accredited
investors pursuant to which it agreed to sell (i) shares of the Company’s common stock, (ii) warrants to purchase shares
of the Company’s common stock, and (iii) certain options to purchase additional shares of, and warrants to purchase shares
of, the Company’s common stock. We previously disclosed the details of this transaction (the “Transaction”) by
current report on Form 8-K filed September 15, 2016.
On November 10, 2016, two of our investors
exercised their options. This exercise resulted in our issuance, in the aggregate, of (a) 667,746 shares of our common stock, par
value $0.01 per share; and (b) warrants to purchase an additional 333,873 of our common stock, par value $0.01 per share (the
“Option Warrants”). The exercise price of the options was $1.94 per share, resulting in aggregate proceeds of $1,295,427.25.
The Option Warrants bear an exercise price of $3.00 per share, and are exercisable for a five-year period expiring on November
10, 2021.
Please refer to Form 8-K filed September
15, 2016, for additional details on the options and Option Warrants, including additional terms related to exercise. As discussed
in that report, we have concluded that the sale of our securities under the Purchase Agreements, and the issuance of securities
upon exercise of the options, was exempt from registration under Securities Act of 1933, as amended, pursuant to Rule 506 of Regulation
D, promulgated thereunder.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereto duly authorized.
Date: November 16, 2016
|
EVINE LIVE INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Damon Schramm
|
|
|
Damon Schramm
Senior Vice President, General Counsel and Secretary
|
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jul 2023 to Jul 2024